Conference item icon

Conference item

Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Nuffield Department of Medicine; Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Nuffield Division of Clinical Laboratory Sciences
Role:
Author
Expand authors...
Publisher:
Wolters Kluwer Publisher's website
Volume:
27
Issue:
S4
Pages:
74
Publication date:
2017-11-01
Acceptance date:
2017-07-01
DOI:
EISSN:
1525-1438
ISSN:
1048-891X
Pubs id:
pubs:824676
URN:
uri:42bf3788-ed9e-48c5-8db3-aa8e560cd854
UUID:
uuid:42bf3788-ed9e-48c5-8db3-aa8e560cd854
Local pid:
pubs:824676

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP